Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-04-17
2007-04-17
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S372000, C514S381000, C514S383000, C514S397000, C514S406000, C514S422000, C548S146000, C548S214000, C548S252000, C548S255000, C548S266200, C548S314700, C548S364100, C548S518000
Reexamination Certificate
active
11250195
ABSTRACT:
The present invention relates to novel compounds useful as dipeptidyl peptidase IV (DPP-IV) inhibitors of the formula:wherein X, Y, a, R1, and R2are as defined herein.
REFERENCES:
patent: 5939560 (1999-08-01), Jenkins et al.
patent: 5952363 (1999-09-01), Kristiansen et al.
patent: 6011155 (2000-01-01), Villhauer
patent: 6166063 (2000-12-01), Villhauer
patent: 2004/0072892 (2004-04-01), Fukushima et al.
patent: 2004/0121964 (2004-06-01), Madar et al.
patent: 2004/0242636 (2004-12-01), Haffner et al.
patent: 2004/0259843 (2004-12-01), Madar
patent: 2005/0192324 (2005-09-01), Thomas et al.
patent: 1 258 476 (2002-11-01), None
patent: 1 323 710 (2003-07-01), None
patent: 1 325 910 (2003-07-01), None
patent: 1333025 (2003-08-01), None
patent: 1 354 882 (2003-10-01), None
patent: 1 464 335 (2004-10-01), None
patent: 1627870 (2006-02-01), None
patent: 2004-026820 (2004-01-01), None
patent: WO-97/40832 (1997-11-01), None
patent: WO-98/19998 (1998-05-01), None
patent: WO-99/50254 (1998-12-01), None
patent: WO-99/50257 (1998-12-01), None
patent: WO-99/50263 (1998-12-01), None
patent: WO-00/02877 (1999-06-01), None
patent: WO-00/34241 (2000-06-01), None
patent: WO-01/46199 (2001-06-01), None
patent: WO-01/55105 (2001-08-01), None
patent: WO-01/96295 (2001-12-01), None
patent: WO-02/02513 (2002-01-01), None
patent: WO-2002/038541 (2002-05-01), None
patent: WO-03/002531 (2003-01-01), None
patent: WO 03002553 (2003-01-01), None
patent: WO-03/037327 (2003-05-01), None
patent: WO-03/074500 (2003-09-01), None
patent: WO-2003/084940 (2003-10-01), None
patent: WO-2004/026822 (2004-04-01), None
patent: WO-2004/087680 (2004-10-01), None
patent: WO 20040101514 (2004-11-01), None
patent: WO-2005/023762 (2005-03-01), None
patent: WO-2005/075426 (2005-08-01), None
Hackh's Chemical Dictionary (1972).
Villhauer E B et al., “1-[[(3-Hydroxy-1-Adamantyl)Amiono] Acetyl] -2-Cyano-(S)-Pyrrolidine: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties”,Journal of Medicinal Chemistry, American Chemical Society. Washington, US, vol. 46, No. 13, 2003, pp. 2774-2789, XP-001165747.
Bioorg. Med. Chem. Lett. 6(10): 1163-1166 (1996).
Bioorg. Med. Chem. Lett. 6(22):2745-2748 (1996).
Balasubramanian Gopalan
Lingam V. S. Prasada Rao
Shah Daisy Manish
Thomas Abraham
Darby & Darby
Freistein Andrew B.
Glenmark Pharmaceuticals S.A.
Shameem Golam M. M.
LandOfFree
Dipeptidyl peptidase IV inhibitors pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dipeptidyl peptidase IV inhibitors pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dipeptidyl peptidase IV inhibitors pharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3753989